Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response

Vaccine

Volumn 17, Issue 19, 1999, Pages 2384-2391

  Novak, Miroslav J ^a   Smythies, Lesley E ^b   McPherson, Sylvia A ^a   Smith, Phillip D ^b,c   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

Helicobacter pylori; Poliovirus replicon; Th1 Th2 immune responses; Urease

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; UREASE;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HELPER CELL; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPRECIPITATION; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPLICON; TRANSGENE;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; BACTERIAL VACCINES; BLOTTING, WESTERN; CAPSID; CAPSID PROTEINS; DNA, BACTERIAL; DNA, VIRAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, TRANSGENIC; PEPTIDE BIOSYNTHESIS; PEPTIDES; POLIOVIRUS; PRECIPITIN TESTS; RECOMBINANT FUSION PROTEINS; REPLICON; TH1 CELLS; UREASE; VACCINATION;

EID: 0033553649     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00035-3     Document Type: Article

References (31)

1. Clayton C.L., Pallen M.J., Kleanthous H., Wren B.W., Tabaqchali S. Nucleotide sequence of two genes from Helicobacter pylori encoding for urease subunits. Nucleic Acids Res. 18:1990;362.
2. Dickinson B.L., Clements J.D. Dissociation of Escherichia coli heat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63:1995;1617-1623.
3. Dubois A., Lee C.K., Fiala N., Kleanthous H., Mehlman P.T., Monath T. Immunization against natural Helicobacter pylori infection in nonhuman primates. Inf. and Immunity. 66:1998;4340-4346.
4. Dunn B.E., Cohen H., Blaser M.J. Helicobacter pylori. Clin. Microbiol. Rev. 10:1997;720-741.
5. Dunn B.E., Perez-Perez G.I., Blaser M.J. Two-dimensionel gell electrophoresis and immunoblotting of Campylobacter pylori proteins. Inf. and Immunity. 57:1989;1825-1833.
6. Eaton K.A., Brooks C.L., Morgan D.R., Krakowka S. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect. Immun. 59:1991;2470-2475.
7. Ferrero R.L., Thiberge J.M., Huerre M., Labigne A. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect. Immun. 62:1994;4981-4989.
8. Harris P.R., Ernst P.B., Kawabata S., Kiyono H., Graham M.F., Smith P.D. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J. Infect. Dis. 178:1998;1516-1520.
9. Lee C.K., Weltzin R., Thomas J.W.D., Kleanthous H., Ermak T.H., Soman G., Hill J.E., Ackerman S.K., Monath T.P. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:1995;161-172.
10. Levine M.M., Kaper J.B., Black R.E., Clements M.L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:1983;510-550.
11. Mai U.E.H., Perez-Perez G.I., Allen J.B., Wahl S.M., Blaser M.J., Smith P.D. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J. Exp. Med. 175:1992;517-525.
12. Mai U.E.H., Perez-Perez G.I., Wahl L.M., Wahl S.M., Blaser M.J., Smith P.D. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by a lipopolysaccharide-independent mechanism. J. Clin. Invest. 87:1991;894-900.
13. Marchetti M., Arico B., Burroni D., Figura N., Rappuoli R., Ghiara P. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science. 267:1995;1655-1658.
14. Michetti P., Corthesy-Theulaz I., Davin C., Haas R., Baney A.-C., Heitz M., Bille J., Kraehenbuhl J.-P., Saraga E., Blum A.L. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology. 107:1994;1002-1011.
15. Michetti P., Kreiss C., Kotloff K., Porta N., Blanco J.L., Bachmann D., Saldinger P.F., Corthesy-Theulaz I., Losonsky G., Nichols R., Stolte M., Monath T., Ackerman S., Blum A.L. Oral immunization of H. pylori infected adults with recombinant urease and LT adjuvant. Gastroenterology. 112:1997;A1042.
16. Mohammadi M., Czinn S., Redline R., Nedrud J. Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice. J. Immunol. 156:1996;4729-4738.
17. Mohammadi M., Nedrud J., Redline R., Lycke N., Czinn S.J. Murine CD4 T-cell response to Helicobacter infection: Th1 cells enhance gastritis and Th2 cells reduce bacterial load. Gastroenterology. 113:1997;1848-1857.
18. Moldoveanu Z., Novak M., Hunag W.-Q., Gilley R.M., Staas J.K., Schafer D., Compans R.W., Mestecky J. Oral immunization with influenza virus in biodegradable microspheres. J. Infect. Dis. 167:1993;84-90.
19. Moldoveanu Z., Porter D.C., Lu A., McPherson S., Morrow C.D. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Vaccine. 13:1995;1013-1022.
20. Porter D.C., Ansardi D.C., Choi W.S., Morrow C.D. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 gag and pol proteins upon infection. J. Virol. 67:1993;3712-3719.
21. Porter D.C., Ansardi D.C., Wang J., McPherson S., Moldoveanu Z., Morrow C.D. Demonstration of the specificity of poliovirus encapsidation using novel replicon which encodes enzymatically active firefly luciferase. Virology. 243:1998;1-11.
22. Raz E., Tighe H., Sato Y., Corr M., Dudler J.A., Roman M., Swain S.L., Spiegelberg H.L., Carson D.A. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. (USA). 93:1996;5141-5145.
23. Ren R., Costantini F., Gorgacz E.J., Lee J.J., Racaniello V.R. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis. Cell. 63:1990;353-362.
24. Sabin A.B., Boulger L.R. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1:1973;115-118.
25. Saldinger P.F., Porta N., Launois P., Louis J.A., Waanders G.A., Bouzourene H., Michetti P., Blum A.L., Corthesy-Theulaz I.E. Immunization of BALB/c mice with Helicobacter Urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology. 115:1998;891-897.
26. Sin J.-I., Kim J.J., Boyer J.D., Ciccarelli R.B., Higgins T.J., Weiner D.B. In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectivness in a Herpes simplex virus type 2 mouse model. J. Virol. 73:1999;501-509.
27. Smythies L.E., Waites K.D., Lindsey J.R., Harris P.R., Ghiara P., Smith P.D., Helicobacter pylori-inducded Th1-mediated gastric inflammation is exacerbated in interleukin-4, but not interferon-γ, -deficient mice. Submitted.
28. Snapper C.M., Paul W.E. Interferon gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236:1987;944-947.
29. Watanabe T., Tada M., Nagai H., Sasaki S., Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology. 115:1998;642-648.
30. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Yamamoto M., Fujihashi K., Van Ginkel F.W., Noda M., Takeda Y., McGhee J.R. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. (USA). 94:1997;5267-5272.
31. Yamamoto S., Takeda Y., Yamamoto M., Kurazono H., Imaoka K., Yamamoto M., Fujihashi K., Noda M., Kiyono H., McGhee J.R. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 185:1997;1203-1210.